Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Genocea Biosciences Inc announces closing of initial public offering


Monday, 10 Feb 2014 12:00pm EST 

Genocea Biosciences Inc:Closes initial public offering of 5,500,000 shares of its common stock at a public offering price of $12.00 per share.Says after underwriting discounts and commissions and estimated offering expenses, Genocea received net proceeds of about $61.4 million, excluding estimated offering expenses.Shares are listed on the NASDAQ Global Market under the ticker symbol GNCA.Citigroup and Cowen and Company are acting as joint book-running managers for the offering.Stifel is acting as lead manager and Needham & Company, LLC is acting as co-manager. 

Company Quote

8.55
1.42 +19.92%
2:16pm EST